Transgenex Nanobiotech, Inc.
Records under this name other than patents Transgenex Nanobiotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Transgenex Nanobiotech, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,520,472 | System and Method of Measuring Cell Viability and Growth Formerly held In force · High confidence | In force | High confidence | |
| US 11,319,311 | Crystalline forms of Actinomycin D for treatment of cancer Lapsed on the fee record Ended May 3, 2026 · USPTO record | Lapsed on the fee record | Ended May 3, 2026 | USPTO record |
| US 8,502,015 | Method of inducing cancer Lapsed on the fee record Ended Aug 6, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2025 | USPTO record |
| US 11,053,254 | Crystalline forms of mitomycin C for treatment of cancer Lapsed on the fee record Ended Jul 6, 2025 · USPTO record | Lapsed on the fee record | Ended Jul 6, 2025 | USPTO record |
| US 11,016,062 | System and Method of Measuring Cell Viability and Growth Formerly held Lapsed on the fee record Ended May 25, 2025 · High confidence | Lapsed on the fee record | Ended May 25, 2025 | High confidence |
| US 10,813,935 | Methods and Compositions for Treating Drug Resistance in Cancer Lapsed on the fee record Ended Oct 27, 2024 · High confidence | Lapsed on the fee record | Ended Oct 27, 2024 | High confidence |
| US 9,091,640 | Chitosan-Graphene Biosensors and Methods for Their Use Lapsed on the fee record Ended Jul 28, 2023 · High confidence | Lapsed on the fee record | Ended Jul 28, 2023 | High confidence |